« The Site and Participant Perspective of eCOA: Ensuring Best Practices. Dr. Elan Cohen was featured in the STARR Coalition podcast. »
Athira Pharma to Host Educational Webinar on the Predictive Nature of P300 to Determine Clinical Benefit of Alzheimer’s Disease Treatments Published October 26, 2020 | By hriadmin